Literature DB >> 8689387

Effects of three inhibitors of nitric oxide synthase on host resistance to bacterial infection.

K Fukatsu1, H Saito, R Fukushima, M T Lin, T Inoue, T Inaba, S Furukawa, I Han, T Muto.   

Abstract

OBJECTIVE: To examine the effects of three nitric oxide synthase inhibitors on survival in a murine sepsis model.
DESIGN: Prospective randomized experimental trials.
SETTING: Laboratory.
SUBJECTS: Female Balb/c mice.
INTERVENTIONS: Escherichia coli (10(8) colony-forming-units/body) were injected into the peritoneal cavities of Balb/c mice. NG-nitro-L-arginine-methyl-ester, NG-monomethyl-L-arginine, or N-iminoethyl-L-ornithine was given at various concentrations, intraperitoneally, one hour before bacterial challenge. MEASUREMENTS: One hundred and fifteen animals were observed for survival.
RESULTS: These inhibitors provided the mice no protection from the bacterial challenge. Notably, pretreatment with NG-nitro-L-arginine-methyl-ester (100 mg/kg i.p.) actually reduced survival time after E. coli challenge.
CONCLUSIONS: Inhibition of nitric oxide production improved neither the survival time nor rate in this murine sepsis model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689387     DOI: 10.1007/bf02265161

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  17 in total

Review 1.  Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens.

Authors:  S J Green; C A Nacy; M S Meltzer
Journal:  J Leukoc Biol       Date:  1991-07       Impact factor: 4.962

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.

Authors:  A Petros; D Bennett; P Vallance
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

4.  Nitric oxide: a cytotoxic activated macrophage effector molecule.

Authors:  J B Hibbs; R R Taintor; Z Vavrin; E M Rachlin
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

5.  Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?

Authors:  E Nava; R M Palmer; S Moncada
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

6.  Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor.

Authors:  T J Rimele; R J Sturm; L M Adams; D E Henry; R J Heaslip; B M Weichman; D Grimes
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

7.  Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.

Authors:  T B McCall; M Feelisch; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

8.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

9.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

10.  Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.

Authors:  F Y Liew; S Millott; C Parkinson; R M Palmer; S Moncada
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

View more
  1 in total

1.  Maternal/fetal mortality and fetal growth restriction: role of nitric oxide and virulence factors in intrauterine infection in rats.

Authors:  Katarzyna Wroblewska-Seniuk; Stella Nowicki; Chantal Le Bouguénec; Bogdan Nowicki; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.